Literature DB >> 17889271

A four-dimensional CT-based evaluation of techniques for gastric irradiation.

Ylanga G van der Geld1, Suresh Senan, John R van Sörnsen de Koste, Wilko F A R Verbakel, Ben J Slotman, Frank J Lagerwaard.   

Abstract

PURPOSE: To evaluate three-dimensional conformal (3D-CRT), intensity-modulated (IMRT) and respiration-gated radiotherapy (RGRT) techniques for gastric irradiation for target coverage and minimization of renal doses. All techniques were four-dimensional (4D)-CT based, incorporating the intrafractional mobility of the target volume and organs at risk (OAR). METHODS AND MATERIALS: The stomach, duodenal C-loop, and OAR (kidneys, liver, and heart) were contoured in all 10 phases of planning 4D-CT scans for five patients who underwent abdominal radiotherapy. Planning target volumes (PTVs) encompassing all positions of the stomach (PTV(all phases)) were generated. Three respiratory phases for RGRT in inspiration and expiration were identified, and corresponding PTV(inspiration) and PTV(expiration) and OAR volumes were created. Landmark-based fields recommended for the Radiation Therapy Oncology Group (RTOG) 99-04 study protocol were simulated to assess PTV coverage. IMRT and 3D-CRT planning with and without additional RGRT planning were performed for all PTVs, and corresponding dose volume histograms were analyzed.
RESULTS: Use of landmark-based fields did not result in full geometric coverage of the PTV(all phases) in any patient. IMRT significantly reduced mean renal doses compared with 3D-CRT (15.0 Gy +/- 0.9 Gy vs. 20.1 Gy +/- 9.3 Gy and 16.6 Gy +/- 1.5 Gy vs. 32.6 Gy +/- 7.1 Gy for the left and right kidneys, respectively; p = 0.04). No significant increase in renal sparing was seen when adding RGRT to either 3D-CRT or IMRT. Tolerance doses to the other OAR were not exceeded.
CONCLUSIONS: Individualized field margins are essential for gastric irradiation. IMRT plans significantly reduce renal doses, but the benefits of RGRT in gastric irradiation appear to be limited.

Entities:  

Mesh:

Year:  2007        PMID: 17889271     DOI: 10.1016/j.ijrobp.2007.06.062

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  Feasibility of automated pancreas segmentation based on dynamic MRI.

Authors:  S Gou; J Wu; F Liu; P Lee; S Rapacchi; P Hu; K Sheng
Journal:  Br J Radiol       Date:  2014-10-01       Impact factor: 3.039

Review 2.  Chemoradiation for gastric cancer: controversies, updates and novel techniques.

Authors:  M Fan; W Hu; Z Zhang
Journal:  Br J Radiol       Date:  2015-04-01       Impact factor: 3.039

3.  Dosimetric impact of gastrointestinal air column in radiation treatment of pancreatic cancer.

Authors:  Neil C Estabrook; Jonathan B Corn; Marvene M Ewing; Higinia R Cardenes; Indra J Das
Journal:  Br J Radiol       Date:  2017-12-22       Impact factor: 3.039

4.  Esophageal cancer dose escalation using a simultaneous integrated boost technique.

Authors:  James Welsh; Matthew B Palmer; Jaffer A Ajani; Zhongxing Liao; Steven G Swisher; Wayne L Hofstetter; Pamela K Allen; Steven H Settle; Daniel Gomez; Anna Likhacheva; James D Cox; Ritsuko Komaki
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-01       Impact factor: 7.038

5.  Volumetric modulated arc therapy for advanced pancreatic cancer.

Authors:  Wietse Eppinga; Frank Lagerwaard; Wilko Verbakel; Ben Slotman; Suresh Senan
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

Review 6.  Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.

Authors:  Greg Knight; Craig C Earle; Roxanne Cosby; Natalie Coburn; Youssef Youssef; Richard Malthaner; Rebecca K S Wong
Journal:  Gastric Cancer       Date:  2012-03-31       Impact factor: 7.370

7.  Daily CT guidance improves target coverage during definitive radiation therapy for gastric MALT lymphoma.

Authors:  He Wang; Sarah A Milgrom; Bouthaina S Dabaja; Grace L Smith; Mary Martel; Chelsea C Pinnix
Journal:  Pract Radiat Oncol       Date:  2017-03-06

8.  Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.

Authors:  James Welsh; Daniel Gomez; Matthew B Palmer; Beverly A Riley; Amin V Mayankkumar; Ritsuko Komaki; Lei Dong; X Ronald Zhu; Anna Likhacheva; Zhongxing Liao; Wayne L Hofstetter; Jaffer A Ajani; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-04       Impact factor: 7.038

9.  Failure patterns in patients with esophageal cancer treated with definitive chemoradiation.

Authors:  James Welsh; Stephen H Settle; Arya Amini; Lianchun Xiao; Akihiro Suzuki; Yuki Hayashi; Wayne Hofstetter; Ritsuko Komaki; Zhongxing Liao; Jaffer A Ajani
Journal:  Cancer       Date:  2011-10-05       Impact factor: 6.860

10.  Microdissection of Human Esophagogastric Junction Wall with Phase-contrast X-ray CT Imaging.

Authors:  Jianfa Zhang; Guangzhao Zhou; Dongping Tian; Runhua Lin; Guanyun Peng; Min Su
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.